Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C26441
http://purl.obolibrary.org/obo/NCIT_C26441
|
|---|---|
| Preferred Name | Iratumumab |
| Definitions |
A fully human monoclonal antibody with potential antineoplastic activity. MDX-060 is a fully humanized antibody that targets CD30, a member of the tumor necrosis factor receptor superfamily found on activated lymphocytes. CD30 is over-expressed in various lymphoproliferative disorders, Hodgkin disease and other lymphomas, and other cancers. (NCI04)
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A fully human monoclonal antibody with potential antineoplastic activity. MDX-060 is a fully humanized antibody that targets CD30, a member of the tumor necrosis factor receptor superfamily found on activated lymphocytes. CD30 is over-expressed in various lymphoproliferative disorders, Hodgkin disease and other lymphomas, and other cancers. (NCI04) |
|---|---|
| prefLabel | Iratumumab
|
| label | Iratumumab
|
| PDQ_Closed_Trial_Search_ID | 301900
|
| code | C26441
|
| Has_Target | |
| prefixIRI | NCIT:C26441
|
| in_subset |
See more
See less
|
| Display_Name | Iratumumab
|
| Preferred_Name | Iratumumab
|
| FDA_UNII_Code | AYH22O1B1U
|
| Contributing_Source |
CTRP
FDA
|
| Maps_To | Iratumumab
|
| CAS_Registry | 640735-09-7
|
| NCI_Drug_Dictionary_ID | 301900
|
| Legacy Concept Name | MDX-060_Monoclonal_Antibody
|
| type | |
| ALT_DEFINITION | A monoclonal antibody that is being studied in the treatment of some lymphomas. Monoclonal antibodies are produced in the laboratory and can locate and bind to cancer cells.
|
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 301900
|
| Semantic_Type |
Amino Acid, Peptide, or Protein
Pharmacologic Substance
Indicator, Reagent, or Diagnostic Aid
|
| UMLS_CUI | C1327954
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |